Effect of Aging on Haemostasis Parameters

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aging Hematologic Diseases Hemic and Lymphatic Diseases Thrombophilia

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Lariboisiere, Paris, France

About this study

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age <40 2 groups : 1 : no history of VTE 2 : history of VTE

Exclusion criteria

antiaggregant or anticoagulant therapy at curative dose
arterial or thrombotic event in the last month

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Hopital Lariboisière

Other

Registry information

Official study title

Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging

Important dates

Study start: 2005
Primary completion: 2006
Study completion: 2006
First posted: Mar 7, 2006
Registry last updated: Sep 14, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed